Tailored Treatment Algorithms, Liquid Biopsy and Personalized Medicine

In this episode of our Therapeutic Science and Strategy Podcast, Joel Sandler, Principal, BioConsulting, Cancer Cell Therapy Lead, sits down with Brian Leyland-Jones, MB BS, PhD, CMO, National Foundation for Cancer Research and Peter Kuhn, PhD, Dean’s Professor of Biological Sciences, Professor of Biological Sciences, Medicine, Biomedical Engineering, Aerospace and Mechanical Engineering and Urology, to explore:

• Historical perspective on personalized approaches to cancer treatment

• Liquid biopsy as a means to facilitate adaptive treatment regimens tailored to individual cancers
• Vision of where the field is going and future management paradigms